Skip to main content
Premium Trial:

Request an Annual Quote

Roche Cobas Liat System

Roche this week announced the launch of its cobas Liat System, a fast, compact molecular diagnostic platform designed for on-demand testing in physician clinics, pharmacies, and hospitals. The PCR-based system is fully automated and can generate test results in as little as 20 minutes, Roche said.

Roche also currently offers two tests on the system: cobas Influenza A/B and cobas Strep A. The Liat system and accompanying assays are both CE marked and cleared by the US Food and Drug Administration. Roche noted that the Liat System is not currently CLIA waived in the US and that testing sites outside the clinical laboratory are not available in all markets.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.